Recent Updates
Recently added Catalysts
INCY Positive Sentiment

Incyte to Present at Upcoming Investor Conferences

Tuesday, September 1, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Incyte has announced its participation in several upcoming investor conferences in September 2026. The company will present at the Wells Fargo Healthcare Conference, Cantor Global Healthcare Conference, and Morgan Stanley Global Healthcare Conference. These presentations will be available via live webcast and for replay for 30 days, highlighting Incyte's focus on investor engagement.
Price reaction · baseline $123.22 (2026-08-31 close) · hit pre-market · clean, no other INCY news in the window
day 0 close · peak
+1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Incyte is actively engaging with investors through multiple conferences.
  • The company showcases its commitment to transparency by providing webcasts.
  • Incyte's portfolio includes innovative medicines across key therapeutic areas.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+34%
120-day peak, hindsight
Typical move
2.4%
average across 15 past catalysts
Lead asset
INCA33890
Phase 1 · Solid Tumors

Full Press Release Details

WILMINGTON, Del. --(BUSINESS WIRE)--Sep. 1, 2026-- Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of September:
• 21st Annual Wells Fargo Healthcare Conference on Wednesday, September 9, 2026 at 11:00 a.m. EDT
• Cantor Global Healthcare Conference 2026 on Thursday, September 10, 2026 at 9:45 a.m. EDT
• Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16, 2026 at 12:20 p.m. EDT
The presentations will be webcast live and can be accessed at Investor.Incyte.com and will be available for replay for 30 days.
About Incyte Incyte is redefining what’s possible in biopharmaceutical innovation. Through deep scientific expertise and a relentless focus on patients, we have built an established portfolio of first-in-class medicines and an extensive portfolio of next-generation medicines across our key franchises: Hematology, Oncology and Inflammation and Autoimmunity.
To learn more, visit Incyte.com and Investor.Incyte.com . Follow us on social media: LinkedIn , X , and Instagram .
View source version on businesswire.com: https://www.businesswire.com/news/home/20260901532380/en/
Incyte Contacts Media media@incyte.com Investors ir@incyte.com
Source: Incyte

Frequently Asked Questions

When will Incyte present at the Wells Fargo Conference?

Incyte will present at the Wells Fargo Healthcare Conference on September 9, 2026.

How can I access Incyte's conference presentations?

The presentations will be webcast live and available for replay at Investor.Incyte.com.

What are the dates of Incyte's investor conferences?

Incyte will present at conferences on September 9, 10, and 16, 2026.

What is Incyte's focus in biopharmaceuticals?

Incyte focuses on hematology, oncology, and inflammation and autoimmunity.

ShareAdd on Google
Tags: INCY Incyte investor conferences Wells Fargo Morgan Stanley biopharmaceuticals
Last updated: Sep 1, 2026

Biotech snapshot

Cash runway
$4536M liquidity · $0M/mo burn
Low dilution risk
Lead asset
INCA33890Phase 1
Solid Tumors →

Catalyst track record

+34%
best trade around INCY's most recent catalyst

Peak hindsight return over a 120-day window, across 15 tracked FDA/PDUFA catalysts for INCY.

See every catalyst's timing & PoA →